The FITC proposes guidelines for health professionals with up-to-date recommendations in France to improve the management of cancer patients treated with immunotherapy.
RECOMMANDATIONS OF THE SOCIETE FRANÇAISE D’IMMUNOTHERAPIE DES CANCERS (FITC) AND THE GROUPE D’IMMUNO-ONCOLOGIE D’UNICANCER (GIO)
CONCERNING THE IMMUNOTHERAPY TREATMENT OF CANCER PATIENTS
IN THE CONTEXT OF THE CORONAVIRUS SARS-CoV-2 EPIDEMIA
How should immune checkpoint inhibitors be managed during the COVID-19 pandemic?
How can you maintain the health of your skin while protecting yourself from COVID-19?
Immunology and virology monitoring of PVVIH patients treated by immunotherapy
Immunology and virology monitoring of PVVIH patients treated with CAR-T cells